1. ACTR-61. A RANDOMIZED PHASE 2 TRIAL OF CEDIRANIB IN COMBINATION WITH OLAPARIB VERSUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA. (11th November 2019) Authors: Arrillaga-Romany, Isabel; Sahebjam, Solmaz; Picconi, David; Campian, Jian; Giglio, Pierre; Drappatz, Jan; Aiken, Robert; Villano, John; Lee, Eudocia; Welch, Mary; Ellingson, Benjamin; Ney, Douglas; Becker, Kevin; Muzikansky, Alona; Das, Biswajit; Swisher, Elizabeth; Nixon, Andrew; Karlovich, Chri... Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗